Roy Geary, regional director for Northern Europe (including the UK) at Ceva Animal Health, said: “The manufacturing of vaccines is a complex process that involves stringent quality control measures and adherence to regulatory guidelines.
"There have been unforeseen manufacturing issues at our production facilities, which have temporarily affected the ability to meet the demands of the UK sheep market within the main seasonal vaccination period for EAE.
"As a responsible provider, we are actively addressing these issues to minimise the impact on customers.
“In collaboration with relevant stakeholders, we have implemented comprehensive contingency plans to optimise the manufacturing and distribution process.
"Our dedicated team is working closely with our partners to resolve the challenges and restore normal supply levels as soon as possible.
"The vaccine challenge is being treated with the utmost urgency, and we are actively exploring alternative sourcing options to supplement the existing supply chain.
“We anticipate that the delay in supply will be resolved in the near future, however we recognise that for some farmers the supply will arrive too late for them to use. "
Ceva is encouraging these farmers to consult their vet and explore alternatives.
Roy added: “We will provide vet practices and the wider industry with regular updates as we progress toward a resolution and return to normal supply levels.”
PS: Whilst you're here, take a moment to see our latest job opportunities for vets.